This study focused on the feasibility of dynamic contrast-enhanced MRI (DCE-MRI) with compressed sensing T1-weighted volumetric interpolated breath-hold examination (csVIBE) for pancreatic ductal adenocarcinoma (PDAC) and correlation with extracellular volume fraction (ECV). Our results indicated that DCE-MRI obtained with csVIBE is feasible for the assessment of PDACs and the ECV fraction can be used in place of DCE-MRI parameters for predicting treatment response or survival in patients with PDAC.
This abstract and the presentation materials are available to members only; a login is required.